Form 4 for INCY Incyte
Accepted 2025-10-06 00:00:00 ET · period of report 2025-10-02 · accession 0001995298-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-06 | 2025-10-02 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $58.06 | +599 | 33.8K | +2% | +$34.8K |
| DM | 2025-10-06 | 2025-10-02+ | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $85.85 | -4,100 | 33.2K | -11% | -$352.0K |
| D | 2025-10-06 | 2025-10-02 | INCY | Denton Sheila A. | EVP, GC | F - Tax | $86.28 | -3,130 | 30.1K | -9% | -$270.1K |
| D | 2025-10-06 | 2025-10-02 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $0.00 | -599 | 14.4K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-02 | M | A | 599 | $58.06 | 33,799 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-03 | S | D | 3,501 | $85.54 | 26,569 | D | — | — | (F2) This includes an aggregate of 25,913 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested. |
| 3 | Common | Common Stock | 2025-10-02 | F | D | 3,130 | $86.28 | 30,070 | D | — | — | (F1) Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. |
| 4 | Common | Common Stock | 2025-10-02 | S | D | 599 | $87.65 | 33,200 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2025-10-02 | M | D | 599 | $0.00 | 14,363 | D | $58.06 · — to 2033-10-02 | 599 Common Stock | (F3) Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years. |